CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Millions	Jun. 30, 2025	Dec. 31, 2024
Current assets
Cash and cash equivalents	$ 1,454	$ 179
Accounts receivable, net	1,133	1,249
Accrued unbilled revenues	822	832
Inventories	668	666
Regulatory assets	621	561
Derivative instruments	255	114
Prepaid taxes	62	72
Prepayments and other	652	652
Total current assets	5,667	4,325
Property, plant and equipment, net	60,751	57,198
Other assets
Nuclear decommissioning fund and other investments	4,087	3,896
Regulatory assets	2,840	2,849
Derivative instruments	60	72
Operating lease right-of-use assets	1,131	1,060
Other	801	635
Total other assets	8,919	8,512
Total assets	75,337	70,035
Current liabilities
Current portion of long-term debt	251	1,103
Short-term debt	820	695
Accounts payable	2,096	1,781
Regulatory liabilities	893	852
Taxes accrued	360	535
Accrued interest	319	280
Dividends payable	337	314
Derivative instruments	27	37
Operating lease liabilities	211	227
Other	572	635
Total current liabilities	5,886	6,459
Deferred credits and other liabilities
Deferred income taxes	5,739	5,319
Regulatory liabilities	6,217	6,010
Asset retirement obligations	3,803	3,713
Derivative instruments	67	77
Customer advances	132	146
Pension and employee benefit obligations	360	477
Operating lease liabilities	945	867
Other	128	129
Total deferred credits and other liabilities	17,391	16,738
Commitments and contingencies
Capitalization
Long-term debt	31,099	27,316
Common stock — 1,000,000,000 shares authorized of $2.50 par value; 591,201,845 and 574,365,598 shares outstanding at June 30, 2025 and December 31, 2024, respectively	$ 1,478	$ 1,436
Common Stock, Shares Authorized	1,000,000,000	1,000,000,000
Common Stock, Par or Stated Value Per Share	$ 2.50	$ 2.50
Common Stock, Shares, Outstanding	591,201,845	574,365,598
Additional paid in capital	$ 10,736	$ 9,601
Retained earnings	8,813	8,553
Accumulated other comprehensive loss	(66)	(68)
Total common stockholders’ equity	20,961	19,522
Total liabilities and equity	$ 75,337	$ 70,035